BLT 4.00% 13.0¢ benitec biopharma limited

Panno response on Tribetarna Trial

  1. 2,168 Posts.
    lightbulb Created with Sketch. 38
    Panno response about Tribetarna trial starting ....

    Author’s reply »The role of tubulin in NSCLC is still being investigated by the team. The work published late last year


    http://bit.ly/18MEYO0


    has identified tubulin's mode of action in NSCLC. This is a significant step in understanding the safety profile of Tribetarna and increases the chances of the FDA approving an IND. Assuming that the biodistribution studies are also close to completion, then the IND application should not be too far away. The only drawback that I can envisage is the biodistribution study MAY throw up some new data that needs additional work to prove the safety profile is complete. If this were to be the case, then we would need more information before the impact of any such findings could be assessed.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist
(20min delay)
Last
13.0¢
Change
0.005(4.00%)
Mkt cap ! $33.41M
Open High Low Value Volume
13.0¢ 13.5¢ 13.0¢ $6.024K 45.30K

Buyers (Bids)

No. Vol. Price($)
1 25921 13.0¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 47188 2
View Market Depth
Last update - 16.10pm 15/02/2019 (20 minute delay) ?
(live)
Last
13.0¢
  Change
0.005 ( 4.00 %)
Open High   Low Volume
13.0¢ 13.0¢   13.0¢ 30771
Last updated 15.22pm 15/02/2019 (live) ?
BLT (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.